We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
-6.45%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$440M
AUM Growth
+$68.3M
Cap. Flow
+$121M
Cap. Flow %
27.55%
Top 10 Hldgs %
7.16%
Holding
1,009
New
355
Increased
190
Reduced
143
Closed
321

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$7.33M
2
AZN icon
AstraZeneca
AZN
+$3.83M
3
SPB icon
Spectrum Brands
SPB
+$3.54M
4
BNS icon
Scotiabank
BNS
+$3.5M
5
TSN icon
Tyson Foods
TSN
+$3.37M

Top Sells

Rank Stock Value
1
VIRT icon
Virtu Financial
VIRT
+$3.48M
2
DOV icon
Dover
DOV
+$2.95M
3
TU icon
Telus
TU
+$2.82M
4
SYK icon
Stryker
SYK
+$2.58M
5
TTWO icon
Take-Two Interactive
TTWO
+$2.49M

Sector Composition

Rank Sector Weight
1 Healthcare 18.71%
2 Technology 17.25%
3 Industrials 13.57%
4 Financials 13.31%
5 Consumer Discretionary 12.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSK icon
1
GSK
GSK
$103B
$5.7M 1.29%
+193,518
New +$7.33M
BNS icon
2
Scotiabank
BNS
$108B
$4.04M 0.92%
84,936
+61,287
+259% +$3.5M
AZN icon
3
AstraZeneca
AZN
$250B
$3.32M 0.75%
+30,230
New +$3.83M
TSN icon
4
Tyson Foods
TSN
$20.5B
$3.06M 0.69%
46,362
+42,572
+1,123% +$3.37M
SEE
5
DELISTED
Sealed Air
SEE
$2.71M 0.62%
+60,884
New +$3.34M
SNY icon
6
Sanofi
SNY
$103B
$2.65M 0.6%
+69,835
New +$3.11M
T icon
7
AT&T
T
$158B
$2.56M 0.58%
+166,575
New +$3.03M
AOS icon
8
A.O. Smith
AOS
$8.59B
$2.55M 0.58%
52,453
+47,027
+867% +$2.7M
CLH icon
9
Clean Harbors
CLH
$16.3B
$2.54M 0.58%
23,100
+18,713
+427% +$2M
CSX icon
10
CSX Corp
CSX
$94.7B
$2.37M 0.54%
88,956
+72,723
+448% +$2.26M
VRSK icon
11
Verisk Analytics
VRSK
$24.6B
$2.28M 0.52%
+13,358
New +$2.5M
ADI icon
12
Analog Devices
ADI
$184B
$2.25M 0.51%
+16,175
New +$2.56M
LDOS icon
13
Leidos
LDOS
$16B
$2.23M 0.51%
+25,484
New +$2.49M
BG icon
14
Bunge Global
BG
$20.5B
$2.2M 0.5%
26,651
-2,871
-10% -$267K
NEOG icon
15
Neogen
NEOG
$2.49B
$2.2M 0.5%
157,328
+116,391
+284% +$2.34M
ZD icon
16
Ziff Davis
ZD
$1.94B
$2.19M 0.5%
31,952
+19,418
+155% +$1.53M
BJ icon
17
BJs Wholesale Club
BJ
$12.3B
$2.14M 0.49%
29,450
+8,435
+40% +$605K
SPB icon
18
Spectrum Brands
SPB
$2.08B
$2.14M 0.49%
+54,834
New +$3.54M
BBWI icon
19
Bath & Body Works
BBWI
$4.19B
$2.11M 0.48%
64,846
+44,482
+218% +$1.57M
CTS icon
20
CTS Corp
CTS
$1.91B
$2.11M 0.48%
50,764
+23,294
+85% +$935K
CNC icon
21
Centene
CNC
$33.1B
$2.09M 0.47%
+26,841
New +$2.4M
SYNH
22
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$2.06M 0.47%
43,746
+37,550
+606% +$2.43M
REGN icon
23
Regeneron Pharmaceuticals
REGN
$79.1B
$2.05M 0.47%
+2,981
New +$1.88M
NUE icon
24
Nucor
NUE
$62.6B
$2.05M 0.47%
19,192
+14,327
+294% +$1.8M
DPZ icon
25
Domino's
DPZ
$12.1B
$2.05M 0.47%
+6,604
New +$2.51M
1
2 3 4 5

Similar funds

BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.9B AUM 2.22% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Campbell & Co Investment Adviser's Q3 2022 Portfolio in Review

As of Q3 2022, Campbell & Co Investment Adviser held 1,009 positions worth $440M, up 18% from $372M the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

Campbell & Co Investment Adviser deployed $121M of net new capital in Q3 2022, opening 355 new positions and adding to 190 existing holdings. Its largest new stake was GSK: 193,518 shares worth $5.7M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Dover, an estimated $2.95M trimmed.

  • Campbell & Co Investment Adviser's largest Q3 2022 buy was GSK: 193,518 shares worth $5.7M.
  • Campbell & Co Investment Adviser added most to Scotiabank in Q3 2022, an estimated $3.5M increase.
  • Campbell & Co Investment Adviser's biggest Q3 2022 reduction was Dover, cutting an estimated $2.95M.
  • Campbell & Co Investment Adviser fully exited Virtu Financial in Q3 2022, selling an estimated $3.48M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 7.2% of its $440M portfolio in Q3 2022.
  • Campbell & Co Investment Adviser opened 355 new positions and closed 321 in Q3 2022.
  • Campbell & Co Investment Adviser's portfolio value rose 18% quarter-over-quarter to $440M.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2022, filed 14 Nov 2022.